$AMGN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMGEN INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AMGEN INC. Get notifications about new insider transactions in AMGEN INC for free.
Page: < prev 1 2 3 4 5 6 ... 27 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 07 2020 | AMGN | AMGEN INC | Griffith Peter H. | EVP & CFO | Option Exercise | A | 236.36 | 28,341 | 6,698,679 | 28,341 | |
May 07 2020 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Option Exercise | A | 236.36 | 5,668 | 1,339,688 | 5,668 | |
May 07 2020 | AMGN | AMGEN INC | Griffith Peter H. | EVP & CFO | Grant | A | 0.00 | 3,384 | 0 | 21,990 | 18.6 K to 22 K (+18.19 %) |
May 07 2020 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Grant | A | 0.00 | 676 | 0 | 24,751 | 24.1 K to 24.8 K (+2.81 %) |
May 07 2020 | AMGN | AMGEN INC | Graham Jonathan P | EVP, Gen. Counsel & ... | Option Exercise | A | 236.36 | 27,633 | 6,531,336 | 27,633 | |
May 07 2020 | AMGN | AMGEN INC | Graham Jonathan P | EVP, Gen. Counsel & ... | Grant | A | 0.00 | 3,300 | 0 | 50,656 | 47.4 K to 50.7 K (+6.97 %) |
May 07 2020 | AMGN | AMGEN INC | Gordon Murdo | EVP Global Commerci ... | Option Exercise | A | 236.36 | 29,050 | 6,866,258 | 29,050 | |
May 07 2020 | AMGN | AMGEN INC | Gordon Murdo | EVP Global Commerci ... | Grant | A | 0.00 | 3,469 | 0 | 37,873 | 34.4 K to 37.9 K (+10.08 %) |
May 07 2020 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Option Exercise | A | 236.36 | 102,031 | 24,116,047 | 102,031 | |
May 07 2020 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Grant | A | 0.00 | 12,184 | 0 | 543,966 | 531.8 K to 544 K (+2.29 %) |
May 07 2020 | AMGN | AMGEN INC | Williams R Sanders | Director | Sell | S | 237.31 | 425 | 100,857 | 5,409 | 5.8 K to 5.4 K (-7.28 %) |
May 07 2020 | AMGN | AMGEN INC | Williams R Sanders | Director | Grant | A | 0.00 | 846 | 0 | 5,834 | 5 K to 5.8 K (+16.96 %) |
May 07 2020 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Grant | A | 0.00 | 846 | 0 | 15,482 | 14.6 K to 15.5 K (+5.78 %) |
May 07 2020 | AMGN | AMGEN INC | Johnston Lori A | EVP, HR | Option Exercise | A | 236.36 | 24,799 | 5,861,492 | 24,799 | |
May 07 2020 | AMGN | AMGEN INC | Kullman Ellen Jamison | Director | Grant | A | 0.00 | 977 | 0 | 6,380 | 5.4 K to 6.4 K (+18.08 %) |
May 07 2020 | AMGN | AMGEN INC | Johnston Lori A | EVP, HR | Grant | A | 0.00 | 2,961 | 0 | 32,268 | 29.3 K to 32.3 K (+10.10 %) |
May 07 2020 | AMGN | AMGEN INC | Jacks Tyler | Director | Grant | A | 0.00 | 846 | 0 | 11,302 | 10.5 K to 11.3 K (+8.09 %) |
May 07 2020 | AMGN | AMGEN INC | HOLLEY CHARLES M | Director | Grant | A | 0.00 | 846 | 0 | 3,975 | 3.1 K to 4 K (+27.04 %) |
May 07 2020 | AMGN | AMGEN INC | HENDERSON REBECCA M | Director | Grant | A | 0.00 | 969 | 0 | 17,974 | 17 K to 18 K (+5.70 %) |
May 07 2020 | AMGN | AMGEN INC | Griffith Peter H. | EVP & CFO | Option Exercise | A | 236.36 | 28,341 | 6,698,679 | 28,341 | |
May 07 2020 | AMGN | AMGEN INC | Griffith Peter H. | EVP & CFO | Grant | A | 0.00 | 3,384 | 0 | 21,990 | 18.6 K to 22 K (+18.19 %) |
May 07 2020 | AMGN | AMGEN INC | Graham Jonathan P | EVP, Gen. Counsel & ... | Option Exercise | A | 236.36 | 27,633 | 6,531,336 | 27,633 | |
May 07 2020 | AMGN | AMGEN INC | Graham Jonathan P | EVP, Gen. Counsel & ... | Grant | A | 0.00 | 3,300 | 0 | 50,656 | 47.4 K to 50.7 K (+6.97 %) |
May 07 2020 | AMGN | AMGEN INC | Gordon Murdo | EVP Global Commerci ... | Option Exercise | A | 236.36 | 29,050 | 6,866,258 | 29,050 | |
May 07 2020 | AMGN | AMGEN INC | Gordon Murdo | EVP Global Commerci ... | Grant | A | 0.00 | 3,469 | 0 | 37,873 | 34.4 K to 37.9 K (+10.08 %) |
May 07 2020 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Option Exercise | A | 236.36 | 102,031 | 24,116,047 | 102,031 | |
May 07 2020 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Grant | A | 0.00 | 12,184 | 0 | 543,966 | 531.8 K to 544 K (+2.29 %) |
May 07 2020 | AMGN | AMGEN INC | Williams R Sanders | Director | Sell | S | 237.31 | 425 | 100,857 | 5,409 | 5.8 K to 5.4 K (-7.28 %) |
May 07 2020 | AMGN | AMGEN INC | Williams R Sanders | Director | Grant | A | 0.00 | 846 | 0 | 5,834 | 5 K to 5.8 K (+16.96 %) |
May 07 2020 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Grant | A | 0.00 | 846 | 0 | 15,482 | 14.6 K to 15.5 K (+5.78 %) |
May 07 2020 | AMGN | AMGEN INC | Kullman Ellen Jamison | Director | Grant | A | 0.00 | 977 | 0 | 6,380 | 5.4 K to 6.4 K (+18.08 %) |
May 07 2020 | AMGN | AMGEN INC | Jacks Tyler | Director | Grant | A | 0.00 | 846 | 0 | 11,302 | 10.5 K to 11.3 K (+8.09 %) |
May 07 2020 | AMGN | AMGEN INC | HOLLEY CHARLES M | Director | Grant | A | 0.00 | 846 | 0 | 3,975 | 3.1 K to 4 K (+27.04 %) |
May 07 2020 | AMGN | AMGEN INC | HENDERSON REBECCA M | Director | Grant | A | 0.00 | 969 | 0 | 17,974 | 17 K to 18 K (+5.70 %) |
May 05 2020 | AMGN | AMGEN INC | Santos Esteban | EVP, Operations | Payment of Exercise | F | 230.98 | 194 | 44,810 | 43,049 | 43.2 K to 43 K (-0.45 %) |
May 05 2020 | AMGN | AMGEN INC | Santos Esteban | EVP, Operations | Payment of Exercise | F | 239.22 | 593 | 141,857 | 43,243 | 43.8 K to 43.2 K (-1.35 %) |
May 05 2020 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Payment of Exercise | F | 230.98 | 185 | 42,731 | 37,939 | 38.1 K to 37.9 K (-0.49 %) |
May 05 2020 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Payment of Exercise | F | 239.22 | 1,046 | 250,224 | 38,124 | 39.2 K to 38.1 K (-2.67 %) |
May 05 2020 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Payment of Exercise | F | 230.98 | 136 | 31,413 | 41,504 | 41.6 K to 41.5 K (-0.33 %) |
May 05 2020 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Payment of Exercise | F | 239.22 | 123 | 29,424 | 41,640 | 41.8 K to 41.6 K (-0.29 %) |
May 05 2020 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Payment of Exercise | F | 230.98 | 127 | 29,334 | 24,075 | 24.2 K to 24.1 K (-0.52 %) |
May 05 2020 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Payment of Exercise | F | 239.22 | 115 | 27,510 | 24,202 | 24.3 K to 24.2 K (-0.47 %) |
May 05 2020 | AMGN | AMGEN INC | Johnston Lori A | EVP, HR | Payment of Exercise | F | 239.22 | 335 | 80,139 | 29,307 | 29.6 K to 29.3 K (-1.13 %) |
May 05 2020 | AMGN | AMGEN INC | Graham Jonathan P | EVP, Gen. Counsel & ... | Payment of Exercise | F | 230.98 | 555 | 128,194 | 47,356 | 47.9 K to 47.4 K (-1.16 %) |
May 05 2020 | AMGN | AMGEN INC | Graham Jonathan P | EVP, Gen. Counsel & ... | Payment of Exercise | F | 239.22 | 549 | 131,332 | 47,911 | 48.5 K to 47.9 K (-1.13 %) |
May 05 2020 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Payment of Exercise | F | 230.98 | 2,759 | 637,274 | 531,782 | 534.5 K to 531.8 K (-0.52 %) |
May 05 2020 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Payment of Exercise | F | 239.22 | 2,737 | 654,745 | 534,541 | 537.3 K to 534.5 K (-0.51 %) |
Apr 29 2020 | AMGN | AMGEN INC | Santos Esteban | EVP, Operations | Payment of Exercise | F | 236.28 | 526 | 124,283 | 43,836 | 44.4 K to 43.8 K (-1.19 %) |
Apr 29 2020 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Payment of Exercise | F | 236.28 | 168 | 39,695 | 39,170 | 39.3 K to 39.2 K (-0.43 %) |
Apr 29 2020 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Payment of Exercise | F | 236.28 | 116 | 27,408 | 41,763 | 41.9 K to 41.8 K (-0.28 %) |
Apr 29 2020 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Payment of Exercise | F | 236.28 | 102 | 24,101 | 24,317 | 24.4 K to 24.3 K (-0.42 %) |
Apr 29 2020 | AMGN | AMGEN INC | Johnston Lori A | EVP, HR | Payment of Exercise | F | 236.28 | 335 | 79,154 | 29,642 | 30 K to 29.6 K (-1.12 %) |
Apr 29 2020 | AMGN | AMGEN INC | Graham Jonathan P | EVP, Gen. Counsel & ... | Payment of Exercise | F | 236.28 | 548 | 129,481 | 48,460 | 49 K to 48.5 K (-1.12 %) |
Apr 29 2020 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Payment of Exercise | F | 236.28 | 2,543 | 600,860 | 537,278 | 539.8 K to 537.3 K (-0.47 %) |
Apr 22 2020 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Option Exercise | M | 54.69 | 1,000 | 54,690 | 9,000 | |
Apr 22 2020 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Sell | S | 233.35 | 1,000 | 233,350 | 14,636 | 15.6 K to 14.6 K (-6.40 %) |
Apr 22 2020 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Buy | M | 54.69 | 1,000 | 54,690 | 15,636 | 14.6 K to 15.6 K (+6.83 %) |
Apr 13 2020 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Option Exercise | M | 58.43 | 84,000 | 4,908,120 | 0 | |
Apr 13 2020 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Option Exercise | M | 58.43 | 43,000 | 2,512,490 | 0 | |
Apr 13 2020 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Payment of Exercise | F | 218.21 | 55,695 | 12,153,206 | 539,821 | 595.5 K to 539.8 K (-9.35 %) |
Apr 13 2020 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Buy | M | 58.43 | 84,000 | 4,908,120 | 595,516 | 511.5 K to 595.5 K (+16.42 %) |
Apr 13 2020 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Payment of Exercise | F | 218.21 | 28,511 | 6,221,385 | 511,516 | 540 K to 511.5 K (-5.28 %) |
Apr 13 2020 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Buy | M | 58.43 | 43,000 | 2,512,490 | 540,027 | 497 K to 540 K (+8.65 %) |
Mar 24 2020 | AMGN | AMGEN INC | Santos Esteban | EVP, Operations | Payment of Exercise | F | 198.76 | 6,465 | 1,284,983 | 44,362 | 50.8 K to 44.4 K (-12.72 %) |
Mar 24 2020 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Payment of Exercise | F | 198.76 | 1,855 | 368,700 | 39,338 | 41.2 K to 39.3 K (-4.50 %) |
Mar 24 2020 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Payment of Exercise | F | 198.76 | 1,481 | 294,364 | 24,419 | 25.9 K to 24.4 K (-5.72 %) |
Mar 24 2020 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Payment of Exercise | F | 198.76 | 1,591 | 316,227 | 41,879 | 43.5 K to 41.9 K (-3.66 %) |
Mar 24 2020 | AMGN | AMGEN INC | Johnston Lori A | EVP, HR | Payment of Exercise | F | 198.76 | 3,709 | 737,201 | 29,977 | 33.7 K to 30 K (-11.01 %) |
Mar 24 2020 | AMGN | AMGEN INC | Graham Jonathan P | EVP, Gen. Counsel & ... | Payment of Exercise | F | 198.76 | 5,796 | 1,152,013 | 49,008 | 54.8 K to 49 K (-10.58 %) |
Mar 24 2020 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Payment of Exercise | F | 198.76 | 27,818 | 5,529,106 | 497,027 | 524.8 K to 497 K (-5.30 %) |
Mar 10 2020 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Option Exercise | M | 58.43 | 1,480 | 86,476 | 0 | |
Mar 10 2020 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Payment of Exercise | F | 210.65 | 780 | 164,307 | 40,985 | 41.8 K to 41 K (-1.87 %) |
Mar 10 2020 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Sell | M | 58.43 | 1,480 | 86,476 | 41,765 | 43.2 K to 41.8 K (-3.42 %) |
Mar 05 2020 | AMGN | AMGEN INC | Santos Esteban | EVP, Operations | Grant | A | 0.00 | 12,991 | 0 | 50,618 | 37.6 K to 50.6 K (+34.53 %) |
Mar 05 2020 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Grant | A | 0.00 | 3,711 | 0 | 40,285 | 36.6 K to 40.3 K (+10.15 %) |
Mar 05 2020 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Grant | A | 0.00 | 3,711 | 0 | 43,411 | 39.7 K to 43.4 K (+9.35 %) |
Mar 05 2020 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Grant | A | 0.00 | 3,711 | 0 | 25,848 | 22.1 K to 25.8 K (+16.76 %) |
Mar 05 2020 | AMGN | AMGEN INC | Johnston Lori A | EVP, HR | Grant | A | 0.00 | 7,423 | 0 | 33,517 | 26.1 K to 33.5 K (+28.45 %) |
Mar 05 2020 | AMGN | AMGEN INC | Graham Jonathan P | EVP, Gen. Counsel & ... | Grant | A | 0.00 | 11,600 | 0 | 54,571 | 43 K to 54.6 K (+26.99 %) |
Mar 05 2020 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Grant | A | 0.00 | 55,683 | 0 | 524,066 | 468.4 K to 524.1 K (+11.89 %) |
Feb 11 2020 | AMGN | AMGEN INC | Johnston Lori A | EVP, HR | Payment of Exercise | F | 231.45 | 462 | 106,930 | 26,094 | 26.6 K to 26.1 K (-1.74 %) |
Feb 11 2020 | AMGN | AMGEN INC | Johnston Lori A | EVP, HR | Payment of Exercise | F | 231.45 | 462 | 106,930 | 26,094 | 26.6 K to 26.1 K (-1.74 %) |
Feb 10 2020 | AMGN | AMGEN INC | Williams R Sanders | Director | Sell | S | 233.72 | 425 | 99,331 | 4,988 | 5.4 K to 5 K (-7.85 %) |
Feb 10 2020 | AMGN | AMGEN INC | Williams R Sanders | Director | Sell | S | 233.72 | 425 | 99,331 | 4,988 | 5.4 K to 5 K (-7.85 %) |
Feb 07 2020 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Sell | S | 229.93 | 9,264 | 2,130,079 | 39,700 | 49 K to 39.7 K (-18.92 %) |
Feb 06 2020 | AMGN | AMGEN INC | HOLLEY CHARLES M | Director | Grant | A | 0.00 | 14 | 0 | 3,106 | 3.1 K to 3.1 K (+0.45 %) |
Dec 13 2019 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Option Exercise | M | 162.60 | 2,875 | 467,475 | 5,839 | |
Dec 13 2019 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Option Exercise | M | 162.60 | 2,875 | 467,475 | 5,839 | |
Dec 13 2019 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Payment of Exercise | F | 235.99 | 2,425 | 572,276 | 48,964 | 51.4 K to 49 K (-4.72 %) |
Dec 13 2019 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Payment of Exercise | F | 235.99 | 2,425 | 572,276 | 48,964 | 51.4 K to 49 K (-4.72 %) |
Dec 13 2019 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Sell | M | 162.60 | 2,875 | 467,475 | 51,389 | 54.3 K to 51.4 K (-5.30 %) |
Dec 13 2019 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Sell | M | 162.60 | 2,875 | 467,475 | 51,389 | 54.3 K to 51.4 K (-5.30 %) |
Nov 25 2019 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Sell | S | 234.36 | 8,737 | 2,047,603 | 49,378 | 58.1 K to 49.4 K (-15.03 %) |
Nov 25 2019 | AMGN | AMGEN INC | Graham Jonathan P | EVP, Gen. Counsel & ... | Sell | S | 230.54 | 9,000 | 2,074,837 | 42,853 | 51.9 K to 42.9 K (-17.36 %) |
Nov 20 2019 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Option Exercise | M | 156.35 | 5,749 | 898,856 | 2,962 | |
Nov 20 2019 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Payment of Exercise | F | 224.50 | 4,870 | 1,093,315 | 48,491 | 53.4 K to 48.5 K (-9.13 %) |
Nov 20 2019 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Buy | M | 156.35 | 5,749 | 898,856 | 53,361 | 47.6 K to 53.4 K (+12.07 %) |
Nov 07 2019 | AMGN | AMGEN INC | Williams R Sanders | Director | Sell | S | 215.45 | 425 | 91,566 | 5,413 | 5.8 K to 5.4 K (-7.28 %) |
Nov 07 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Option Exercise | M | 54.71 | 2,000 | 109,420 | 0 | |
Nov 07 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Sell | S | 215.45 | 2,000 | 430,900 | 14,436 | 16.4 K to 14.4 K (-12.17 %) |
Nov 07 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Buy | M | 54.71 | 2,000 | 109,420 | 16,436 | 14.4 K to 16.4 K (+13.85 %) |
Nov 05 2019 | AMGN | AMGEN INC | Johnston Lori A | EVP, HR | Grant | A | 0.00 | 7,799 | 0 | 26,457 | 18.7 K to 26.5 K (+41.80 %) |
Nov 05 2019 | AMGN | AMGEN INC | Graham Jonathan P | EVP, Gen. Counsel & ... | Grant | A | 0.00 | 9,176 | 0 | 51,853 | 42.7 K to 51.9 K (+21.50 %) |
Nov 05 2019 | AMGN | AMGEN INC | Gordon Murdo | EVP Global Commerci ... | Payment of Exercise | F | 217.95 | 5,812 | 1,266,725 | 34,024 | 39.8 K to 34 K (-14.59 %) |
Nov 05 2019 | AMGN | AMGEN INC | Kullman Ellen Jamison | Director | Grant | A | 0.00 | 261 | 0 | 5,335 | 5.1 K to 5.3 K (+5.14 %) |
Nov 05 2019 | AMGN | AMGEN INC | HOLLEY CHARLES M | Director | Grant | A | 0.00 | 153 | 0 | 3,073 | 2.9 K to 3.1 K (+5.24 %) |
Oct 03 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Option Exercise | M | 54.71 | 2,000 | 109,420 | 2,000 | |
Oct 03 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Sell | S | 193.58 | 2,000 | 387,160 | 14,436 | 16.4 K to 14.4 K (-12.17 %) |
Oct 03 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Buy | M | 54.71 | 2,000 | 109,420 | 16,436 | 14.4 K to 16.4 K (+13.85 %) |
Sep 04 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Option Exercise | M | 54.71 | 2,000 | 109,420 | 4,000 | |
Sep 04 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Sell | S | 206.70 | 2,000 | 413,400 | 14,336 | 16.3 K to 14.3 K (-12.24 %) |
Sep 04 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Buy | M | 54.71 | 2,000 | 109,420 | 16,336 | 14.3 K to 16.3 K (+13.95 %) |
Sep 04 2019 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Option Exercise | M | 162.60 | 2,875 | 467,475 | 5,839 | |
Sep 04 2019 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Option Exercise | M | 156.35 | 5,749 | 898,856 | 2,962 | |
Sep 04 2019 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Sell | S | 208.07 | 4,802 | 999,139 | 22,097 | 26.9 K to 22.1 K (-17.85 %) |
Sep 04 2019 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Sell | S | 208.07 | 2,875 | 598,193 | 26,899 | 29.8 K to 26.9 K (-9.66 %) |
Sep 04 2019 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Buy | M | 162.60 | 2,875 | 467,475 | 29,774 | 26.9 K to 29.8 K (+10.69 %) |
Sep 04 2019 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Sell | S | 208.07 | 5,749 | 1,196,178 | 26,899 | 32.6 K to 26.9 K (-17.61 %) |
Sep 04 2019 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Buy | M | 156.35 | 5,749 | 898,856 | 32,648 | 26.9 K to 32.6 K (+21.37 %) |
Aug 08 2019 | AMGN | AMGEN INC | Williams R Sanders | Director | Sell | S | 183.04 | 425 | 77,792 | 5,838 | 6.3 K to 5.8 K (-6.79 %) |
Aug 08 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Option Exercise | M | 54.71 | 2,000 | 109,420 | 6,000 | |
Aug 08 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Sell | S | 183.04 | 2,000 | 366,080 | 14,336 | 16.3 K to 14.3 K (-12.24 %) |
Aug 08 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Buy | M | 54.71 | 2,000 | 109,420 | 16,336 | 14.3 K to 16.3 K (+13.95 %) |
Aug 06 2019 | AMGN | AMGEN INC | Kullman Ellen Jamison | Director | Grant | A | 0.00 | 160 | 0 | 5,041 | 4.9 K to 5 K (+3.28 %) |
Aug 06 2019 | AMGN | AMGEN INC | HOLLEY CHARLES M | Director | Grant | A | 0.00 | 93 | 0 | 2,899 | 2.8 K to 2.9 K (+3.31 %) |
Aug 06 2019 | AMGN | AMGEN INC | Graham Jonathan P | SVP, Gen. Counsel & ... | Payment of Exercise | F | 187.22 | 6,785 | 1,270,288 | 42,610 | 49.4 K to 42.6 K (-13.74 %) |
Aug 02 2019 | AMGN | AMGEN INC | Santos Esteban | EVP, Operations | Payment of Exercise | F | 186.58 | 2,043 | 381,183 | 37,437 | 39.5 K to 37.4 K (-5.17 %) |
Jul 08 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Option Exercise | M | 54.71 | 2,000 | 109,420 | 8,000 | |
Jul 08 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Sell | S | 187.58 | 2,000 | 375,160 | 14,336 | 16.3 K to 14.3 K (-12.24 %) |
Jul 08 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Buy | M | 54.71 | 2,000 | 109,420 | 16,336 | 14.3 K to 16.3 K (+13.95 %) |
Jun 05 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Option Exercise | M | 54.71 | 2,000 | 109,420 | 10,000 | |
Jun 05 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Sell | S | 175.68 | 2,000 | 351,360 | 14,219 | 16.2 K to 14.2 K (-12.33 %) |
Jun 05 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Buy | M | 54.71 | 2,000 | 109,420 | 16,219 | 14.2 K to 16.2 K (+14.07 %) |
May 07 2019 | AMGN | AMGEN INC | Santos Esteban | EVP, Operations | Option Exercise | A | 177.31 | 34,460 | 6,110,103 | 34,460 | |
May 07 2019 | AMGN | AMGEN INC | Santos Esteban | EVP, Operations | Grant | A | 0.00 | 3,947 | 0 | 39,329 | 35.4 K to 39.3 K (+11.16 %) |
May 07 2019 | AMGN | AMGEN INC | Santos Esteban | EVP, Operations | Payment of Exercise | F | 176.50 | 182 | 32,123 | 35,382 | 35.6 K to 35.4 K (-0.51 %) |
May 07 2019 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Option Exercise | A | 177.31 | 39,382 | 6,982,822 | 39,382 | |
May 07 2019 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Grant | A | 0.00 | 4,511 | 0 | 36,075 | 31.6 K to 36.1 K (+14.29 %) |
May 07 2019 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Payment of Exercise | F | 176.50 | 174 | 30,711 | 31,564 | 31.7 K to 31.6 K (-0.55 %) |
May 07 2019 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Option Exercise | A | 177.31 | 14,768 | 2,618,514 | 14,768 | |
May 07 2019 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Grant | A | 0.00 | 1,691 | 0 | 47,555 | 45.9 K to 47.6 K (+3.69 %) |
May 07 2019 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Payment of Exercise | F | 176.50 | 182 | 32,123 | 45,864 | 46 K to 45.9 K (-0.40 %) |
May 07 2019 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Option Exercise | A | 177.31 | 7,876 | 1,396,494 | 7,876 | |
May 07 2019 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Grant | A | 0.00 | 902 | 0 | 26,877 | 26 K to 26.9 K (+3.47 %) |
May 07 2019 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Payment of Exercise | F | 176.50 | 174 | 30,711 | 25,975 | 26.1 K to 26 K (-0.67 %) |
May 07 2019 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Option Exercise | A | 177.31 | 39,382 | 6,982,822 | 39,382 | |
May 07 2019 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Grant | A | 0.00 | 4,511 | 0 | 57,903 | 53.4 K to 57.9 K (+8.45 %) |
May 07 2019 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Payment of Exercise | F | 176.50 | 795 | 140,318 | 53,392 | 54.2 K to 53.4 K (-1.47 %) |
May 07 2019 | AMGN | AMGEN INC | Johnston Lori A | SVP, HR | Option Exercise | A | 177.31 | 17,722 | 3,142,288 | 17,722 | |
May 07 2019 | AMGN | AMGEN INC | Johnston Lori A | SVP, HR | Grant | A | 0.00 | 2,030 | 0 | 18,535 | 16.5 K to 18.5 K (+12.30 %) |